Trending...
- Boston: Mayor Michelle Wu Announces City's Black History Month Programming
- Boston: February is Black History Month
- Boston: Mayor Wu Announces New Road Safety Ordinance to Increase Accountability of Third Party Delivery Providers
CAMBRIDGE, Mass. and LONDON, Nov. 28, 2023 ~ Flagship Pioneering, the bioplatform innovation company, today marked the official launch of its UK presence with an event co-hosted in partnership with the UK Government's Office for Life Sciences. The event brought together top leaders from industry, government, and academia to focus on breakthrough innovation and marked Flagship's public announcement of its strategic commitment to the UK life sciences ecosystem.
The move was driven by the country's strong commitment to scientific research and development, as well as its regulatory environment that supports a culture of innovation. Flagship has established an office in London, its first such office outside the United States. The new office will serve as a regional hub for Flagship's operations in the UK and into Europe.
Noubar Afeyan, Founder and CEO of Flagship Pioneering said: "We are pleased to officially debut the UK effort today, which has been expanding behind the scenes for over a year. With our announced regional hubs in both London and Singapore, Flagship aims to strengthen its position as a global leader in the biotech industry and enhance its ability to engage stakeholders around the world."
More on Boston Chron
Earlier this month, Flagship announced its expansion into the Asia-Pacific region with the establishment of a hub in Singapore and appointment of André Andonian as Chair of Asia Pacific and Senior Advisor. The company creates and builds platform companies designed to generate multiple products that secure a healthier and more sustainable future. For more than 20 years, Flagship has originated and fostered more than 100 scientific ventures resulting in more than $90 billion (USD) in aggregate value. The current Flagship ecosystem comprises 40 impactful companies spanning human therapeutics, agriculture, and nutrition.
Last week's unveiling of Quotient Therapeutics marks its first company co-anchored in both Cambridge MA (US) and Cambridge (UK). Quotient's platform was created by Flagship scientists in partnership with leading geneticists at the Wellcome Sanger Institute (UK) and University of Texas Southwestern (US).
Michelle Donelan, Secretary of State for Science Innovation & Technology said: "From Brunel's engineering revolution in 19th century through to breakthroughs in genetic medicine 21st century British ideas have changed world because willingness ask big questions do things differently but be successful our innovators risk-takers need backing." She added that "Flagship Pioneering choosing UK home Europe another vote confidence mission put real financial firepower behind world-leading science backing brightest ideas serious capital help deliver improved healthcare new medical treatments high-skill jobs."
More on Boston Chron
Tom Kibasi Senior Vice President & UK Initiative Lead said: "The UK offers immense opportunities collaboration academic institutions research centers national data resources biotech startups we look forward continuing work closely biotech community contributing advancement scientific research development country."
Professor Lord Darzi who chairs Preemptive Health & Medicine initiative added: "The official debut Flagship UK strong growing team London comes time when biotech sector experiencing tremendous growth innovation no doubt make tremendous contribution vibrant innovative biotech ecosystem United Kingdom—benefit too."
The move was driven by the country's strong commitment to scientific research and development, as well as its regulatory environment that supports a culture of innovation. Flagship has established an office in London, its first such office outside the United States. The new office will serve as a regional hub for Flagship's operations in the UK and into Europe.
Noubar Afeyan, Founder and CEO of Flagship Pioneering said: "We are pleased to officially debut the UK effort today, which has been expanding behind the scenes for over a year. With our announced regional hubs in both London and Singapore, Flagship aims to strengthen its position as a global leader in the biotech industry and enhance its ability to engage stakeholders around the world."
More on Boston Chron
- Boston: Article 85 Hearing - BLC - February 25, 2025 at 6 p.m.
- Boston: Request for Comments HOME-ARP Allocation Plan - Amendment #2
- Earn passive income through DAY Miner cloud mining in 2025
- Vane Airport Media Inc, The Best Travel Idea of 2025
- HVAC Systems: The Unsung Heroes in the Fight Against Flu Season
Earlier this month, Flagship announced its expansion into the Asia-Pacific region with the establishment of a hub in Singapore and appointment of André Andonian as Chair of Asia Pacific and Senior Advisor. The company creates and builds platform companies designed to generate multiple products that secure a healthier and more sustainable future. For more than 20 years, Flagship has originated and fostered more than 100 scientific ventures resulting in more than $90 billion (USD) in aggregate value. The current Flagship ecosystem comprises 40 impactful companies spanning human therapeutics, agriculture, and nutrition.
Last week's unveiling of Quotient Therapeutics marks its first company co-anchored in both Cambridge MA (US) and Cambridge (UK). Quotient's platform was created by Flagship scientists in partnership with leading geneticists at the Wellcome Sanger Institute (UK) and University of Texas Southwestern (US).
Michelle Donelan, Secretary of State for Science Innovation & Technology said: "From Brunel's engineering revolution in 19th century through to breakthroughs in genetic medicine 21st century British ideas have changed world because willingness ask big questions do things differently but be successful our innovators risk-takers need backing." She added that "Flagship Pioneering choosing UK home Europe another vote confidence mission put real financial firepower behind world-leading science backing brightest ideas serious capital help deliver improved healthcare new medical treatments high-skill jobs."
More on Boston Chron
- Capstone Partners & IMAP Release 2024-2025 Trends in Global M&A Research Survey:
- Gold Coast Health Plan Distributes $225,000 for Fire Relief and Preparedness Efforts
- The Dallas Group of America, Inc. Celebrates the 50th Anniversary of Landmark Facility
- Boston: Mayor Michelle Wu Announces Annual Tax Prep Services Available for Residents
- Dog Licensing Reminder (and Boston's Most Popular Dog Names!)
Tom Kibasi Senior Vice President & UK Initiative Lead said: "The UK offers immense opportunities collaboration academic institutions research centers national data resources biotech startups we look forward continuing work closely biotech community contributing advancement scientific research development country."
Professor Lord Darzi who chairs Preemptive Health & Medicine initiative added: "The official debut Flagship UK strong growing team London comes time when biotech sector experiencing tremendous growth innovation no doubt make tremendous contribution vibrant innovative biotech ecosystem United Kingdom—benefit too."
Filed Under: Business
0 Comments
Latest on Boston Chron
- Brooke Shields Announced as a Keynote Speaker at the 2025 Simmons Leadership Conference
- The Elevated Table Project Revolutionizes Cannabis-Infused Cooking & Cocktails
- Boston: Mayor Wu Announces City's Black History Month Programming
- THSYU Opens New Doors for Accredited Investors, Bridging the Gap Between Traditional Finance and the Digital Asset Frontier
- Mardi Gras Annual Party w/Revolutionary Snake Ensemble + guests Jason Palmer & Henri Smith
- Boston: Mayor Michelle Wu Announces City's Black History Month Programming
- Latest DivX 11 Software Advances Video Playback, Conversion, and Streaming
- Gold Coast Health Plan Among State's Top Performers for Outstanding Health Care Quality
- NETRF Awards Ten Groundbreaking Research Grants to Advance Neuroendocrine Cancer Treatment
- Boston: Mayor Wu Announces New Road Safety Ordinance to Increase Accountability of Third Party Delivery Providers
- Boston: February is Black History Month
- Leon Jackson and Nicole McNeil Married in Boston
- A New Way to Think About Anxiety
- NC Health Official Urges Ban on Wilderness Therapy Camps Following Child's Death
- Greentown Labs Names Georgina Campbell Flatter as Incoming Chief Executive Officer
- Breaking Barriers & Elevating Voices: The Top 50 Over 50 Podcast Awards Set to Make History!
- Videeko Vanilla Partners with Nosy Foundation with a Commitment to a Thriving Madagascar
- The Power Of Online Reviews & Why They Matter
- Darlease Monteiro Named Director of School Culture at Global Learning Charter Public School
- Boston: Council Recognizes Oldest Living Tuskegee Airmen